Avista Healthcare Partners Completes Sale of Solmetex to AGIC Capital
- Editor
- Mar 19
- 2 min read
Whats Happening:
Avista Healthcare Partners has successfully completed the sale of Solmetex, a leading provider of dental products and solutions, to AGIC Capital. The transaction marks the end of Avista's four-year partnership with Solmetex, during which the company experienced significant growth and expanded its product portfolio through strategic acquisitions.
Key Moves:
Avista Healthcare Partners sells Solmetex to AGIC Capital
Solmetex expanded through three strategic acquisitions during Avista's ownership
Avista retains a minority stake in Solmetex to support future growth
By The Numbers:
Avista Healthcare Partners has over $8 billion invested in more than 45 healthcare businesses
AGIC Capital has $2.2 billion in assets under management
Solmetex is the largest closed-loop dental amalgam waste compliance service provider in North America
Key Quotes:
"We have greatly valued our partnership with the Solmetex management team, supporting their significant growth over the past four years," - Sriram Venkataraman, Partner at Avista
"I have tremendous gratitude for Avista's instrumental support in helping Solmetex grow from the largest closed-loop dental amalgam waste compliance service provider in North America to a multiple product and water solutions provider to dentists," - Gene Dorff, CEO of Solmetex
"We are excited to embark on the next chapter with AGIC Capital as our partner. Their industry expertise and commitment to growth align seamlessly with our vision for Solmetex," - Gene Dorff, CEO of Solmetex
Bottom Line:
The successful sale of Solmetex to AGIC Capital demonstrates Avista Healthcare Partners' ability to create value in the healthcare sector. This transaction highlights the growing interest in dental technology and services, while also showcasing the potential for private equity firms to drive growth and innovation in specialized healthcare markets.
Comments